These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23542818)

  • 1. Endocrine effects of chemicals: aspects of hazard identification and human health risk assessment.
    Dekant W; Colnot T
    Toxicol Lett; 2013 Dec; 223(3):280-6. PubMed ID: 23542818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment of 'endocrine substances': guidance on identifying endocrine disruptors.
    Lewis RW
    Toxicol Lett; 2013 Dec; 223(3):287-90. PubMed ID: 24036001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
    Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refinement of the ECETOC approach to identify endocrine disrupting properties of chemicals in ecotoxicology.
    Weltje L; Wheeler JR; Weyers A; Galay-Burgos M
    Toxicol Lett; 2013 Dec; 223(3):291-4. PubMed ID: 23467018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECETOC Florence workshop on risk assessment of endocrine substances, including the potency concept.
    Fegert I
    Toxicol Lett; 2013 Dec; 223(3):310-4. PubMed ID: 23558296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Science based guidance for the assessment of endocrine disrupting properties of chemicals.
    Bars R; Broeckaert F; Fegert I; Gross M; Hallmark N; Kedwards T; Lewis D; O'Hagan S; Panter GH; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):37-46. PubMed ID: 20858523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enhancement of the subacute repeat dose toxicity test OECD TG 407 for the detection of endocrine active chemicals: comparison with toxicity tests of longer duration.
    Gelbke HP; Hofmann A; Owens JW; Freyberger A
    Arch Toxicol; 2007 Apr; 81(4):227-50. PubMed ID: 17047927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles.
    Dietrich DR; von Aulock S; Marquardt H; Blaauboer B; Dekant W; Kehrer J; Hengstler J; Collier A; Gori GB; Pelkonen OP; Lang F; Nijkamp FP; Stemmer K; Li A; Savolainen K; Hayes A; Gooderham N; Harvey A
    Toxicol In Vitro; 2013 Oct; 27(7):2110-4. PubMed ID: 23850741
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of three approaches for regulatory decision making on pesticides with endocrine disrupting properties.
    Marx-Stoelting P; Niemann L; Ritz V; Ulbrich B; Gall A; Hirsch-Ernst KI; Pfeil R; Solecki R
    Regul Toxicol Pharmacol; 2014 Dec; 70(3):590-604. PubMed ID: 25239592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment of endocrine disrupting chemicals--introduction to this special issue.
    van Ravenzwaay B; Dekant W; Vrijhof H
    Toxicol Lett; 2013 Dec; 223(3):269-70. PubMed ID: 24140152
    [No Abstract]   [Full Text] [Related]  

  • 11. Background to the ADI/TDI/PTWI.
    Herrman JL; Younes M
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S109-13. PubMed ID: 10597623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human health.
    Harvey PW; Everett DJ
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):145-65. PubMed ID: 16522525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening chemicals for thyroid-disrupting activity: A critical comparison of mammalian and amphibian models.
    Pickford DB
    Crit Rev Toxicol; 2010 Nov; 40(10):845-92. PubMed ID: 20684730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary.
    Beausoleil C; Ormsby JN; Gies A; Hass U; Heindel JJ; Holmer ML; Nielsen PJ; Munn S; Schoenfelder G
    Chemosphere; 2013 Oct; 93(6):847-56. PubMed ID: 23932820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental effect assessment for sexual endocrine-disrupting chemicals: Fish testing strategy.
    Knacker T; Boettcher M; Frische T; Rufli H; Stolzenberg HC; Teigeler M; Zok S; Braunbeck T; Schäfers C
    Integr Environ Assess Manag; 2010 Oct; 6(4):653-62. PubMed ID: 20872646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, assessment and management of "endocrine disruptors" in wildlife in the EU substance legislation--discussion paper from the German Federal Environment Agency (UBA).
    Frische T; Bachmann J; Frein D; Juffernholz T; Kehrer A; Klein A; Maack G; Stock F; Stolzenberg HC; Thierbach C; Walter-Rohde S
    Toxicol Lett; 2013 Dec; 223(3):306-9. PubMed ID: 23500481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act.
    Stevens JT; Tobia A; Lamb JC; Tellone C; O'Neal F
    J Toxicol Environ Health; 1997 Apr; 50(5):415-31. PubMed ID: 9140462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology.
    Kortenkamp A
    Int J Androl; 2008 Apr; 31(2):233-40. PubMed ID: 18248400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.